October 20, 2023 05:27 AM EDTUpdated 08:40 AM
Peer Review

Co-found­ed by David Bak­er, Vilya rings in a per­ma­nent CEO; Al­lo­gene names Er­ic Schmidt's CFO suc­ces­sor

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Ex-Ole­ma On­col­o­gy chief Cyrus Har­mon has resur­faced as CEO of Vilya, a Seat­tle-based macro­cy­cle biotech from David Bak­er’s lab that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times